Dynavax Technologies | GÆLD

Debt Lave om Dato
AbbVie USD 74B 13.26B 2024-03
Adma Biologics USD 141.43M 10.83M 2024-03
Amgen USD 64.02B 593M 2024-03
AstraZeneca USD 34.55B 5.93B 2024-03
Biogen USD 6.95B 8.4M 2024-03
BioMarin Pharmaceutical USD 1.1B 9.56M 2024-03
Bristol-Myers Squibb USD 57.41B 17.64B 2024-03
Dynavax Technologies USD 251.54M 28.84M 2024-03
Gilead Sciences USD 25.19B 212M 2024-03
Glaxosmithkline GBP 17.77B 246M 2024-03
Merck USD 34.22B 640M 2024-03
Neurocrine Biosciences USD 511.9M 342M 2024-03
Novartis USD 27.28B 936M 2024-03
Pfizer USD 68.71B 5.11B 2024-03
Regeneron Pharmaceuticals USD 2.7B 400K 2024-03
Roche Holding CHF 29.21B 3.82B 2023-12
Sarepta Therapeutics USD 1.38B 142.59M 2024-03
TG Therapeutics USD 111.67M 12.76M 2024-03
Vertex Pharmaceuticals USD 721.3M 331M 2024-03



Dynavax Technologies GÆLD - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Jun 2024.